Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Transdermal Gels in the Treatment of Diabetic Neuropathy

Author(s):  Hodges Caroline J, Jones Thomas H, Willoughby David L

Issue:  Mar/Apr 2000 - Compounding for Diabetes Patients
View All Articles in Issue

Page(s):  91-93

Transdermal Gels in the Treatment of Diabetic Neuropathy Page 1
Transdermal Gels in the Treatment of Diabetic Neuropathy Page 2
Transdermal Gels in the Treatment of Diabetic Neuropathy Page 3

Download in electronic PDF format for $65

Abstract:  Diabetic neuropathy refers to a large number of clinical syndromes affecting both the autonomic and peripheral nervous systems and both type 1 and type 2 diabetes patients. In this article, the authors place particular emphasis on the use of ketamine Pluronic lecithin organogels for treating diabetic neuropathy. They also discuss the etiology of diabetic neuropathy, its clinical presentation, pain management (glycemic control, tricyclic antidepressants, anticonvulsants, ketamine and autonomic agents) and provide three brief case reports describing the use of a polymedicine formula . They conclude that medications administered by transdermal gels are a viable option and potentially the most rewarding for a compounding pharmacist, as they allow pain relief with fewer adverse effects. The real challenge is deciding whether the patient should begin with the polymedicine formula or with ketamine 10% and amitriptyline 2%, with additional ingredients added as needed to determine the optimal combination of medications for analgesic effects. More research is needed to determine the best combination of agents.

Related Keywords: diabetic neuropathy, ketamine PLO gel, hyperglycemia, shooting pain, burning pain, allodynia, hyperpathia, glycemic control, tricyclic antidepressants, anticonvulsants, gabapentin, ketamine, NMDA receptor antagonist, phantom limb pain, clonidine, baclofen

Related Categories: DIABETES, WOUND CARE

Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Transdermal Gels in the Treatment of Diabetic Neuropathy
Hodges Caroline J
, Jones Thomas H, Willoughby David L
Mar/Apr 2000
Pg. 91-93

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Jones Marty
Jan/Feb 2000
Pg. 6-15

Ketamine for Pain in Hospice Patients
Wood Robert M
Jul/Aug 2000
Pg. 253-254

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016
Pg. 517-520